IMPA2 and bipolar disorder: Similarly, lithium inhibits IMPA1 and IMPA2 activity, pointing to the broad impact of lithium on suppression of IP metabolism [57,58], with IMPA2 additionally identified as a susceptibility gene in bipolar disorder [59], schizophrenia [60] and febrile seizures [61].